Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CDOP vs R-CHOP in Elderly DLBCL
NCT02428751Phase 3Unknown
- Start
- Sep 2015
- Primary completion
- Mar 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin in diffuse large B-cell lymphoma (DLBCL). Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02428751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428751.